Skip to main content

Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients

NAVRKALOVA, V., K. PLEVOVA, L. RADOVÁ, J. PORC, K. PAL, J. MALCIKOVA, S. PAVLOVA, M. DOUBEK, A. PANOVSKA, J. KOTASKOVA, S. POSPISILOVA
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patients. British Journal of Haematology. 2024, 24(1), 240-249, ISSN: 0007-1048, PMID: 38062779,  PDF.